Related Experiment Video
Updated: Jul 16, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Sequential evolution of antidote and toxin links genetic incompatibility with immune responses
Dongying Xie1,2, Yiming Ma1, Junhui Zeng1
1Department of Biology, Hong Kong Baptist University, Hong Kong Special Administrative Region, China.
Abstract:
Toxin-antidote (TA) systems are selfish genetic elements that ensure their own inheritance by eliminating offspring that do not inherit the module, thereby creating postzygotic genetic incompatibilities both within and between species. Despite their ubiquity and substantial fitness costs, the origin and persistence of TA systems remain poorly understood. Here, we report a TA gene pair in the nematode Caenorhabditis nigoni. The antidote gene, Cni-shls-2, is a C. nigoni-specific F-box gene that arose through recent tandem duplications, leading to three identical copies. Its absence results in embryonic lethality in both C. nigoni and its hybrids with the sister species Caenorhabditis briggsae. This lethality is mediated by a maternally deposited toxin, Cni-hlix-1, a chimeric gene formed by the fusion of duplicated host sequences with novel sequences that could be derived from bacteria/archaea. Analysis of evolutionary trajectory of the TA genes among various populations suggests that the antidote is more likely to predate the toxin. These results support a possible model of TA origin, in which Cni-shls-2 initially evolved under pathogen pressure, whereas the subsequent emergence of the toxin enforces antidote retention. We speculate that host-pathogen conflict may serve as a key driving force in the evolution and maintenance of TA systems, inadvertently leading to reproductive barriers.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Cross-reactivity
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Transduction
Drug Toxicity: Allergic Reactions

